Rush University Medical Center

 

Rush University Medical Center
E

What is New in AML: Risk Classification, Germline Mutations, and Targeted Therapies

By Rush University Medical Center FEATURING Ehab Atallah
By Rush University Medical Center FEATURING Ehab Atallah
222 views
May 29, 2024
Comments 0
Login to view comments. Click here to Login

Featured Video

12:23
Hematology Content

An ITP Case Study of Treating a Patient Who Was Non-responsive to St…

Feat. J. Bussel

Featured Video

03:15
Lilly Medical Affairs

Unmet Needs and Resistance Mechanisms in Patients With HR+, HER2- MB…

Feat. W. Mchayleh
3rd Midwest Cellular Conference: Treatment Options for Advanced Hematologic Malignancies
21:13

The Role of SCT Amidst Emerging Therapies in the Treatment of AL Amy…

Rush University Medical Center

V. Sanchorawala

35 views
20:38

BCMA & Beyond: Novel Targets for Immunotherapy in MM

Rush University Medical Center

B. Derman

158 views
25:52

CAR-T vs. Bispecific Antibodies in R/R MM: Insights and Future Direc…

Rush University Medical Center

A. Suvannasankha

195 views
20:18

Challenges and Treatment Strategies in Advanced Stage Hodgkin Lympho…

Rush University Medical Center

S. Ahmed

43 views
16:19

Advancements in Richter's Transformation: Novel Agents and Cellular …

Rush University Medical Center

F. Awan

42 views
18:10

Optimal Timing of CAR T-Cell Therapies in MCL: Cellular Therapy and …

Rush University Medical Center

S. Nathan

15 views
20:36

Off the Shelf CARs for DLBCL: Myths and Facts

Rush University Medical Center

V. Bachanova

27 views
22:02

High-Risk Myeloma: Updates in Defining and Managing

Rush University Medical Center

J. Zonder

132 views
25:12

Bone Marrow Failure: The Importance of Mutational Testing

Rush University Medical Center

J. Shammo

260 views
20:40

What is New in AML: Risk Classification, Germline Mutations, and Tar…

Rush University Medical Center

E. Atallah

222 views
21:28

Cellular Therapy Strategies for Persistent Disease After Induction f…

Rush University Medical Center

V. Pullarkat

51 views
23:15

Is Post-HSCT Maintenance the SOC for AML?

Rush University Medical Center

M. Levis

298 views
20:47

Transplant-Associated TMA: Challenges and Current Treatment Options

Rush University Medical Center

S. Giralt

224 views
25:38

Allo-HSCT Conditioning Regimens: Current Status and Future Directions

Rush University Medical Center

C. Brunstein

260 views
22:30

Selection and Sequencing of Chronic GVHD Therapy

Rush University Medical Center

S. Kosuri

256 views
23:37

Management of Viral Infections Post-Transplant: CMV, EBV, and HHV-6

Rush University Medical Center

E. Bhaimia

331 views